AstraZeneca PLC
LSE:AZN
AstraZeneca PLC
Total Assets
AstraZeneca PLC
Total Assets Peer Comparison
Competitive Total Assets Analysis
Latest Figures & CAGR of Competitors
Company | Total Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
AstraZeneca PLC
LSE:AZN
|
Total Assets
$102.3B
|
CAGR 3-Years
16%
|
CAGR 5-Years
11%
|
CAGR 10-Years
6%
|
|
GlaxoSmithKline PLC
LSE:GSK
|
Total Assets
£58.5B
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
4%
|
|
Verona Pharma PLC
NASDAQ:VRNA
|
Total Assets
$308.1m
|
CAGR 3-Years
15%
|
CAGR 5-Years
26%
|
CAGR 10-Years
N/A
|
|
Indivior PLC
LSE:INDV
|
Total Assets
$1.5B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
N/A
|
|
Hikma Pharmaceuticals PLC
LSE:HIK
|
Total Assets
$4.7B
|
CAGR 3-Years
4%
|
CAGR 5-Years
6%
|
CAGR 10-Years
9%
|
|
Dechra Pharmaceuticals PLC
LSE:DPH
|
Total Assets
£1.6B
|
CAGR 3-Years
8%
|
CAGR 5-Years
9%
|
CAGR 10-Years
14%
|
See Also
What is AstraZeneca PLC's Total Assets?
Total Assets
102.3B
USD
Based on the financial report for Mar 31, 2024, AstraZeneca PLC's Total Assets amounts to 102.3B USD.
What is AstraZeneca PLC's Total Assets growth rate?
Total Assets CAGR 10Y
6%
Over the last year, the Total Assets growth was 6%. The average annual Total Assets growth rates for AstraZeneca PLC have been 16% over the past three years , 11% over the past five years , and 6% over the past ten years .